CC BY 4.0 · Arq Neuropsiquiatr 2024; 82(S 02): S53-S176
DOI: 10.1055/s-0045-1807107
ID: 722
Area: Inborn errors of metabolism
Presentation method: Eletronic Poster

Neurological recovery in MELAS syndrome: a case report

Isadora de Castro Leite Alcantara
1   Hospital Infantil Lucídio Portella, Teresina PI, Brazil.
2   Universidade Federal do Piauí, Teresina PI, Brazil.
,
Simone Soares Lima
1   Hospital Infantil Lucídio Portella, Teresina PI, Brazil.
2   Universidade Federal do Piauí, Teresina PI, Brazil.
,
Marcela Amaral Avelino Jacobina
1   Hospital Infantil Lucídio Portella, Teresina PI, Brazil.
2   Universidade Federal do Piauí, Teresina PI, Brazil.
,
Carolina Campelo Lima Sousa
,
Luana Araujo Martins
,
Jaci de Lourdes Sousa Costa
,
Juliano Coimbra Uchoa Leitao
1   Hospital Infantil Lucídio Portella, Teresina PI, Brazil.
2   Universidade Federal do Piauí, Teresina PI, Brazil.
,
Angelica Maria Assunçao da Ponte Lopes
1   Hospital Infantil Lucídio Portella, Teresina PI, Brazil.
2   Universidade Federal do Piauí, Teresina PI, Brazil.
,
Joao Guilherme Campelo Brandim de Sa Lopes
› Author Affiliations
 

    *Correspondence: alcantaraisadorac@gmail.com.

    Abstract

    Case Presentation: Female patient, eleven years, presented headache, tremors, and dysarthria and recurrent seizures. Two years earlier, she had been hospitalized due to fever, vomiting, headache, tremors, and nystagmus. Brain MRI at the time showed diffuse vasogenic and cytotoxic edema in the left occipital and parietal lobes. She was treated for encephalitis and discharged. In the family history, her mother died of an astrocytoma at the age of 24. Brain MRI showed T2-weighted and FLAIR hypersignal, with swelling effect, involving the cortical-subcortical transition of the parietal-occipital-temporal region on the left. The study of proton spectroscopy showed a reduction in the peaks of N-acetyl aspartate, choline, and creatine, with an increase in the peaks of lipids and lactate, suggesting the diagnosis of Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. She was treated with a maintenance dose of L-arginine, Coenzyme Q10, L-carnitine, and creatine. The patient presented frequent vomiting and significant neurological dysfunction, unable to interact, communicate or walk. Then, L-carnitine and creatine were suspended, and fluoxetine and lamotrigine were started. In the third month, the vomiting episodes ceased, and the patient showed significant neurological improvement, being able to walk, talk, eat, paint, and recognize figures.

    Discussion: MELAS syndrome is a rare disease, but it is the most common mitochondrial encephalopathy. Occurs by maternal inheritance of pathogenic mtDNA variants, commonly associated with MT-TL1 gene mutations. There is a peak incidence in childhood, around 8 years of age, and another in adults, around 40 years. Clinical manifestations of MELAS include recurrent vomiting, headache, seizures, and neurological changes. Neurologic deficits after stroke-like episodes tend to progress over time to dementia.

    Final Comments: MELAS syndrome is an important differential diagnosis for stroke-like conditions in the pediatric population. Treatment is supportive and rehabilitation is important for patients' neurological recovery and prevention of dementia.


    #

    Publication History

    Article published online:
    12 May 2025

    © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil